Table 2.

Birth Outcomes of MA-exposed pregnancies compared with non-MA exposed pregnancies

	All women (n=251)			Women with no other drug use (n=119)
	Any MA use during pregnancy n=144	No MA use during pregnancy n=107		Only MA during pregnancy n=60	No drug use during pregnancy n=59
Outcome	Mean ± SD	Mean ± SD	p-value	Mean ± SD	Mean ± SD	p-value
Gestational age (weeks)	38.5 ± 2.0	39.1 ± 2.1	0.048	38.8 ± 2.1	39.5 ± 1.6	0.043
Birth Weight (grams)	3159 ± 561	3168 ± 533	0.9	3103 ± 537	3321 ± 451	0.019
Head Circumference (cm)	33.5 ± 3.2	33.9 ± 2.9	0.42	33.2 ± 3.4	34.6 ± 1.5	0.01
Length (cm)	50.3 ± 3.0	50.6 ± 3.4	0.52	49.8 ± 3.4	51.3 ± 2.5	0.009
Cord pH	7.25 ± 0.1	7.27 ± 0.1	0.18	7.25 ± 0.1	7.27 ± 0.1	0.26
Maternal LOS (days)	2.7 ± 1.3	2.4 ± 1.2	0.12	2.52 ± 0.9	2.2 ± 0.8	0.02
Infant LOS (days)	3.9 ± 7.0	3.5 ± 4.7	0.62	4.3 ± 7.8	2.5 ± 1.9	0.1
First prenatal visit (weeks)	23.3 ± 9.5	17.7 ± 9.5	<0.0001	24.2 ± 9.4	17.2 ± 10.4	0.0009
Number of prenatal visits	7 ± 4.3	8.4 ± 3.9	0.018	7.5 ± 4.4	8.6 ±4.2	0.22